Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Exp Cell Res ; 303(2): 343-59, 2005 Feb 15.
Article in English | MEDLINE | ID: mdl-15652348

ABSTRACT

The protein dlk, encoded by the Dlk1 gene, belongs to the Notch epidermal growth factor (EGF)-like family of receptors and ligands, which participate in cell fate decisions during development. The molecular mechanisms by which dlk regulates cell differentiation remain unknown. By using the yeast two-hybrid system, we found that dlk interacts with Notch1 in a specific manner. Moreover, by using luciferase as a reporter gene under the control of a CSL/RBP-Jk/CBF-1-dependent promoter in the dlk-negative, Notch1-positive Balb/c 14 cell line, we found that addition of synthetic dlk EGF-like peptides to the culture medium or forced expression of dlk decreases endogenous Notch activity. Furthermore, the expression of the gene Hes-1, a target for Notch1 activation, diminishes in confluent Balb/c14 cells transfected with an expression construct encoding for the extracellular EGF-like region of dlk. The expression of Dlk1 and Notch1 increases in 3T3-L1 cells maintained in a confluent state for several days, which is associated with a concomitant decrease in Hes-1 expression. On the other hand, the decrease of Dlk1 expression in 3T3-L1 cells by antisense cDNA transfection is associated with an increase in Hes-1 expression. These results suggest that dlk functionally interacts in vivo with Notch1, which may lead to the regulation of differentiation processes modulated by Notch1 activation and signaling, including adipogenesis.


Subject(s)
Membrane Proteins/metabolism , Receptors, Cell Surface/metabolism , Transcription Factors/metabolism , 3T3-L1 Cells , Animals , Base Sequence , Basic Helix-Loop-Helix Transcription Factors , Cell Line , DNA, Antisense/genetics , Epidermal Growth Factor/chemistry , Epidermal Growth Factor/genetics , Epidermal Growth Factor/metabolism , Gene Expression Regulation , Genes, Reporter , Homeodomain Proteins/chemistry , Homeodomain Proteins/genetics , Homeodomain Proteins/metabolism , Humans , In Vitro Techniques , Intracellular Signaling Peptides and Proteins , Luciferases/genetics , Membrane Proteins/chemistry , Membrane Proteins/genetics , Mice , Receptor, Notch1 , Receptors, Cell Surface/chemistry , Receptors, Cell Surface/genetics , Recombinant Proteins/chemistry , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Repetitive Sequences, Amino Acid , Transcription Factor HES-1 , Transcription Factors/chemistry , Transcription Factors/genetics , Transfection , Two-Hybrid System Techniques
2.
J Biol Chem ; 278(8): 5630-8, 2003 Feb 21.
Article in English | MEDLINE | ID: mdl-12454016

ABSTRACT

The major histocompatibility complex class I (MHC1) molecule plays a crucial role in cytotoxic lymphocyte function. beta 2-Microglobulin (beta 2m) has been demonstrated to be both a structural component of the MHC1 complex and a chaperone-like molecule for MHC1 folding. beta 2m binding to an isolated alpha 3 domain of MHC1 heavy chain at micromolar concentrations has been shown to accurately model the biochemistry and thermodynamics of beta 2m-driven MHC1 folding. These results suggested a model in which the chaperone-like role of beta 2m is dependent on initial binding to the alpha 3 domain interface of MHC1 with beta 2m. Such a model predicts that a mutant beta 2m molecule with an intact MHC1 alpha 3 domain interaction but a defective MHC1 alpha 1 alpha 2 domain interaction would block beta2m-driven folding of MHC1. In this study we generated such a beta 2m mutant and demonstrated that it blocks MHC1 folding by normal beta 2m at the expected micromolar concentrations. Our data support an initial interaction of beta 2m with the MHC1 alpha 3 domain in MHC1 folding. In addition, the dominant negative mutant beta 2m can block T-cell functional responses to antigenic peptide and MHC1.


Subject(s)
Genes, Dominant , Histocompatibility Antigens Class I/genetics , beta 2-Microglobulin/genetics , Amino Acid Substitution , Animals , Base Sequence , Cell Line , Cloning, Molecular , DNA Primers , Genes, MHC Class I , Histocompatibility Antigens Class I/metabolism , Humans , Lymphoma, T-Cell , Molecular Sequence Data , Mutagenesis, Site-Directed , Polymerase Chain Reaction , Protein Folding , Protein Structure, Secondary , Recombinant Proteins/metabolism , T-Lymphocytes, Cytotoxic/immunology , Transfection , Tumor Cells, Cultured , beta 2-Microglobulin/chemistry , beta 2-Microglobulin/metabolism
3.
J Immunol ; 169(10): 5514-21, 2002 Nov 15.
Article in English | MEDLINE | ID: mdl-12421927

ABSTRACT

There are two distinct phenotypes of T cell cytokine responses that lead to different effector functions and different outcomes in disease processes. Although evidence suggests a possible role of the local microenvironment in the differentiation or localization of T cells with these phenotypes, there are no examples of divergent T cell cytokine phenotypes with the same Ag specificity concurrently existing in different tissue compartments. Using a CD8(+) T cell adoptive transfer model for graft-vs-host disease, we demonstrate that a potent type 2 cytokine response develops in the spleen while a potent type 1 cytokine response simultaneously develops in the testis. These experiments demonstrate for the first time that cytokine production can be oppositely polarized in different organs of the same individual. This may have important implications for organ-specific pathology in infection or autoimmunity: infections or autoimmune diseases that affect multiple organs may have heterogeneity in tissue cytokine responses that is not revealed in systemic lymphocyte cytokine responses. Therefore, attempts to modulate the immune response phenotype may ameliorate pathology in one organ while exacerbating pathology in another.


Subject(s)
Adoptive Transfer/methods , Cytokines/biosynthesis , T-Lymphocyte Subsets/transplantation , Animals , CD8-Positive T-Lymphocytes/cytology , CD8-Positive T-Lymphocytes/immunology , Cell Movement/genetics , Cell Movement/immunology , Chemokine CCL2/biosynthesis , Dose-Response Relationship, Immunologic , Immunophenotyping , Lymph Nodes/cytology , Lymph Nodes/immunology , Lymph Nodes/metabolism , Lymphocyte Activation/genetics , Male , Mice , Mice, Inbred C57BL , Mice, Transgenic , Organ Specificity/genetics , Organ Specificity/immunology , Receptors, Chemokine/biosynthesis , Spleen/cytology , Spleen/immunology , Spleen/metabolism , T-Lymphocyte Subsets/cytology , T-Lymphocyte Subsets/immunology , T-Lymphocyte Subsets/metabolism , Testis/cytology , Testis/immunology , Testis/metabolism , Th1 Cells/immunology , Th1 Cells/metabolism , Th2 Cells/immunology , Th2 Cells/metabolism
4.
Blood ; 99(7): 2518-25, 2002 Apr 01.
Article in English | MEDLINE | ID: mdl-11895788

ABSTRACT

Movement of T-lymphocyte cell surface CD43 is associated with both antigen activation of T-cell clones and chemokine induction of T-lymphocyte motility. Here, we demonstrate that CD43 movement away from the site of T-cell receptor ligation occurs in unprimed CD4(+) T cells as well as T-cell clones. The T-cell receptor (TCR)-dependent movement of CD43 in unprimed T cells is associated with a polarized morphology and CD43 accumulation at the uropods of the cells, unlike that reported for primed T cells. The polarization of CD43 has a requirement for Src kinases and occurs in conjunction with lipid raft coalescence. Thymocytes and T-cell hybridomas, cells that have altered responses to TCR activation and lack lipid raft coalescence, do not polarize CD43 as readily as unprimed T cells. The movement of CD43 depends on the cholesterol biosynthetic pathway enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase. Blockade of this enzyme can specifically prevent CD43 redistribution without affecting cell shape polarization. The likely mechanism of this alteration in CD43 redistribution is through decreased protein prenylation because the cholesterol-dependent lipid rafts still coalesce on activation. These findings suggest that the polarization of cell shape, lipid raft coalescence, and CD43 redistribution on T-cell activation have signaling pathway distinctions. Dissecting out the relationships between various stages of molecular redistribution and lymphocyte activation may facilitate fine-tuning of immunologic responses.


Subject(s)
Antigens, CD , Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology , Lovastatin/analogs & derivatives , Lovastatin/pharmacology , Membrane Microdomains/physiology , Mevalonic Acid/analogs & derivatives , Mevalonic Acid/pharmacology , Pyrimidines/pharmacology , Sialoglycoproteins/immunology , T-Lymphocytes/immunology , Animals , Cell Polarity/immunology , Female , Leukosialin , Mice , Mice, Inbred BALB C , Microscopy, Fluorescence , Spleen/immunology , T-Lymphocytes/cytology , T-Lymphocytes/drug effects , src-Family Kinases/antagonists & inhibitors
5.
Exp Cell Res ; 274(2): 178-88, 2002 Apr 01.
Article in English | MEDLINE | ID: mdl-11900478

ABSTRACT

The EGF-like membrane protein dlk plays a crucial role in the control of cell differentiation. Overexpression of the protein prevents, whereas inhibition of its expression increases, adipocyte differentiation of 3T3-L1 cells in response to Insulin-like Growth Factor I (IGF-1) or insulin. We have investigated whether dlk modulates the signaling pathways known to control this process. We found that the levels of dlk expression modulated signaling through the IGF-1 receptor, causing changes in the activation levels and kinetics of Extracellular-Regulated Kinase/Mitogen-Activated Protein Kinase (ERK/MAPK) that correlated with differentiation outcome. These changes occurred in response to IGF-1 or insulin but not in response to Epidermal Growth Factor. However, the levels of expression of IGF-1 receptor, or the activation of Insulin Receptor Substrate-1 in response to IGF-1, were not affected by the levels of dlk expression. Therefore, dlk appears to modulate ERK/MAPK signaling in response to specific differentiation signals.


Subject(s)
Cell Differentiation/physiology , Cell Membrane/metabolism , Insulin-Like Growth Factor I/metabolism , MAP Kinase Signaling System/physiology , Membrane Proteins/deficiency , Mitogen-Activated Protein Kinases/metabolism , Receptor, IGF Type 1/metabolism , 3T3 Cells , Adipose Tissue/drug effects , Adipose Tissue/metabolism , Animals , Cell Differentiation/drug effects , Cell Membrane/drug effects , Enzyme Inhibitors/pharmacology , Gene Expression Regulation/drug effects , Gene Expression Regulation/physiology , Insulin/pharmacology , Insulin-Like Growth Factor I/pharmacology , Intracellular Signaling Peptides and Proteins , MAP Kinase Signaling System/drug effects , Membrane Proteins/genetics , Mice , Mitogen-Activated Protein Kinases/drug effects , Phosphatidylinositol 3-Kinases/metabolism , Phosphoinositide-3 Kinase Inhibitors , Receptor, IGF Type 1/drug effects
6.
Biochem Biophys Res Commun ; 291(2): 193-204, 2002 Feb 22.
Article in English | MEDLINE | ID: mdl-11846389

ABSTRACT

Levels of dlk, an EGF-like homeotic protein, are critical for several differentiation processes. Because growth and differentiation are, in general, exclusive of each other, and increasing evidence indicates that Dlk1 expression changes in tumorigenic processes, we studied whether dlk could also affect cell growth. We found that, in response to glucocorticoids, Balb/c 3T3 cells with diminished levels of dlk expression develop foci-like cells that have lost contact inhibition, display altered morphology, and grow faster than control cell lines. Balb/c 3T3 cells spontaneously growing more rapidly are also dlk-negative cells. Moreover, screening by the yeast two-hybrid system, using Dlk1 constructs as baits, resulted in the isolation of GAS1 and acrogranin cDNAs. Interestingly, these proteins are cysteine-rich molecules involved in the control of cell growth. Taken together, these observations suggest that dlk may participate in a network of interactions controlling how the cells respond to growth or differentiation signals.


Subject(s)
Cell Division , Growth Substances , Homeodomain Proteins/metabolism , Homeodomain Proteins/physiology , Intercellular Signaling Peptides and Proteins , Membrane Proteins/metabolism , Membrane Proteins/physiology , 3T3 Cells , Animals , Cell Cycle Proteins , Epidermal Growth Factor/genetics , GPI-Linked Proteins , Glycoproteins/chemistry , Glycoproteins/genetics , Glycoproteins/metabolism , Granulins , Homeodomain Proteins/chemistry , Homeodomain Proteins/genetics , Humans , Intracellular Signaling Peptides and Proteins , Membrane Proteins/chemistry , Membrane Proteins/genetics , Mice , Mice, Inbred BALB C , Progranulins , Protein Structure, Tertiary , RNA, Messenger/biosynthesis , Repetitive Sequences, Amino Acid , Two-Hybrid System Techniques , Yeasts/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...